CancerNetwork Members: Login | Register
CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » EHR

 

Four Ways to Prepare for Stage 2 Rules of Meaningful Use

By Aubrey Westgate | September 13, 2012

Here are four things you should start doing now to prepare for Stage 2 of the Medicare/Medicaid EHR Incentive Programs.    

1. Partner Well
Make sure you are working with the right partner. That means if you are at the very start of the meaningful use process and haven’t yet selected an EHR vendor, do so carefully.

(MORE: Meaningful Use Stage 2 Crib Sheet)

Your success throughout the meaningful use process will largely depend on the vendor you selected. First, make sure that your EHR will be upgraded throughout the meaningful use process (Stages 1, 2, and 3) to comply with the certification requirements in each of the stages.

“If you do not have a vendor currently or are looking to change, make sure your conversations include the Stage 2 requirements as part of the discussions, and mandate [Stage 2] compliance in any contract negotiations,” Nick van Terheyden, MD, CMIO at Nuance Healthcare, told Physicians Practice via e-mail. 

In addition, the EHR you select must be user-friendly. Though this seems like a no-brainer, many practices report dissatisfaction with their first EHR. Research firm KLAS recently found that half of EHR systems sold to physician practices are replacements, according to Medscape. One reason for dissatisfaction with EHRs cited by practices: Unmet expectations and concerns about ability to meet meaningful use. Make sure you make the right EHR vendor choice — the first time.

“There are horrific stories in the industry from Stage 1, and now leading into Stage 2, of offices literally getting crippled by an overly burdensome system — that would either cost too much, impede an office’s work flow, or simply not implement and support an office towards achieving meaningful use,” pediatric physical medicine and rehabilitation specialist Chuck Dietzen, chief medical officer at iSalus Healthcare, told Physicians Practice via e-mail. “Considering the timelines, and the money involved, and most importantly, the patient care — an office has got to fully vet a software provider ... or shall I say a software partner who is experienced, cost effective, and proven.”

2. Partner Up
As Dietzen mentions, your EHR vendor should not only be your provider, it should also be your partner. Keep that in mind while going through the meaningful use process. Your vendor should serve as a valuable resource to you.

If you have already completed Stage 1, begin working with your vendor now to determine how it will assist you with completing Stage 2.

“Work closely with your EHR provider to help you through the [meaningful use] process,” Brian Zimmerman, physician and co-founder of consulting company Physician Technology Partners and current Epic Physician Champion for the emergency department at Miami Valley Hospital, told Physicians Practice via e-mail. “Many of the EHR companies have already positioned themselves well to help with these [Stage 2] requirements.”

3. Start Now
If you have already attested to Stage 1, start preparing for Stage 2 now. Though it doesn’t begin until 2014, those practices that recognize it’s going to take a long time to get ready for participation will have a much easier time.

In fact, according to Laura Kreofsky, principal of healthcare technology consulting firm Impact Advisors, LLC, the key area of risk physicians have for Stage 2 is “complacency, or under-appreciating the level of effort preparing for and performing against the Stage 2 requirements.”

Start digesting the Stage 2 requirements now, determine how you will fulfill them, and plan for the necessary work flow modifications you would need to make.

“Most of the requirements in Stage 2 build off of Stage 1, explicitly or otherwise,” Kreofsky told Physicians Practice. “The requirements that are most nuanced and complicated, such as the summary of care record at transitions of care, will require careful analysis and planning of technology, workflow and practices, and reporting, likely over a several month-period.”

4. Plan Ahead
Know where you stand on the spectrum of Stage 2 participation difficulty level. In other words, some of you should expect a more challenging process than others.

For instance, physicians with many elderly patients may have a harder time fulfilling the patient-engagement related requirements because their patients may be less tech-savvy.

In addition, geography could be a barrier for some of you. “The rural communities, they may have a bigger challenge working with their patient populations who don’t regularly interact with as much technology as more urban patients,” Kreofsky said.  “When you sort of think about technology adoption as a whole it will follow that pattern.”

If you’re among the physicians who will encounter these additional challenges, consider building up a population of highly engaged patients now, so that come 2014, you will be ready.

 

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.

Learn all about the Stage 2 rules for the EHR Incentive Programs:

Why Stage 2 Rules for Meaningful Use May be Harder for Physicians

Physicians React to Meaningful Use Stage 2 Final Rule

Meaningful Use Requirements: Stage 1 vs. Stage 2

Meaningful Use: Payments, Incentives, and Penalties

Four Ways to Prepare for Stage 2 Rules of Meaningful Use

Meaningful Use Stage 2 Crib Sheet





CancerNetwork on Facebook


 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
   SEARCH MEDICA RX
   Browse drugs by name:
A B C D E F G H I J
K L M N O P Q R S T
U V W X Y Z All      
   Search for drugs:
Search

 

 
FROM PHYSICIANS PRACTICE
Key Differences between FQHCs and RHCs
Chastity Werner, RHIT, June 13, 2013
FQHCs and RHCs take up a unique niche among physician practices. And that affects compensation and billing.
Improving Care Coordination in Your Practice
Susanne Madden,  June 12, 2013
Practices are feverishly working to control the rising costs of healthcare - effective care coordination can help.
Refunding Overpayments: Two Options for Medical Practices
Ericka L. Adler,  June 12, 2013
Medicare and Medicaid providers must return overpayments once identified. Here are two different refund approaches for practices to consider when necessary.
Four Easy Ways to Boost Patient Time of Service Collections
Aubrey Westgate,  June 12, 2013
Simple ways your medical practice staff can increase the likelihood patients will pay when presenting for appointments.
iPad Alternatives for Mobile Physicians
Marisa Torrieri, June 11, 2013
As more physicians are seeing the merits of media tablets, the market is expanding, too.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Papillary Thyroid Carcinoma
  • Robotic-Assisted Radical Prostatectomy: Who Is Benefiting?
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • A 48-Year-Old Woman With Irregular Vaginal Bleeding
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Cannabis Linked to Decreased Bladder Cancer Risk
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Rising PSA Level in a 46-Year-Old Man
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Soluble HER2 Levels Prognostic Factor in HER2+ Breast Cancer
  • ASCO: PD-L1 Antibody Elicits Durable Response in RCC
  • RECORD-3: Sunitinib Still Standard First-Line Treatment in Metastatic RCC
  • ASCO: Dabrafenib Shows Activity in BRAF-Mutated NSCLC Patients
  • Preventing Burnout in Oncology
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • Preventing Exposure to Hazardous Drugs
  • ASCO: Vinegar Screening Significantly Reduces Cervical Cancer Mortality
  • ASCO: Sulforaphane in Prostate Cancer Found Worthy of Further Investigation
  • Study: Recurrent Heartburn Ups Risk for Throat Cancer
  • Radiation-Induced Enteritis: Incidence, Mechanisms, and Management
  • HER2-Directed Therapy for Metastatic Breast Cancer
  • Accelerated Partial-Breast Irradiation: The Current State of Our Knowledge
  • It’s Time for Clinicians to Reconsider Their Proscription Against the Use of Soyfoods by Breast Cancer Patients
  • 50 Shades of Pink—And Why It Helps to Know the Difference
Click here to subscribe to our newsletter


 
SearchMedica Search Result

Find peer-reviewed literature and websites for practicing medical professionals

CME on EHR
Evidence on EHR
Guidelines on EHR
Patient Education on EHR
Clinical Trials on EHR
Practical Articles on EHR
Research and Reviews on EHR
All "EHR" results


CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy